FLT3 and acute myeloid leukemia: Our present study suggests that the AML cell biology for a subset of NPM1-insertion (INS)/fms-related receptor tyrosine kinase 3-internal tandem duplications (FLT3-ITD) negative non-responders differs from other non-responders, including NPM1-INS positive non-responders.